المؤلفون: Margaux Sala, Nathalie Allain, Mélanie Moreau, Arnaud Jabouille, Elodie Henriet, Aya Abou-Hammoud, Arnaud Uguen, Sylvaine Di-Tommaso, Cyril Dourthe, Anne-Aurélie Raymond, Jean-William Dupuy, Emilie Gerard, Nathalie Dugot-Senant, Benoit Rousseau, Jean-Phillipe Merlio, Anne Pham-Ledart, Béatrice Vergier, Sophie Tartare-Deckert, Violaine Moreau, Frédéric Saltel

المساهمون: BoRdeaux Institute in onCology (Inserm U1312 - BRIC), Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM), Johns Hopkins University (JHU), Microbiologie Fondamentale et Pathogénicité (MFP), Université Bordeaux Segalen - Bordeaux 2-Centre National de la Recherche Scientifique (CNRS), Hôpital Morvan - CHRU de Brest (CHU - BREST ), TBM-Core [Bordeaux] (CNRS UMS 3427 - INSERM US 005), Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Bordeaux (UB), CHU Bordeaux [Bordeaux], Bordeaux Research In Translational Oncology [Bordeaux] (BaRITOn), Université de Bordeaux (UB)-CHU Bordeaux [Bordeaux]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre méditerranéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UCA), TARTARE-DECKERT, Sophie

المصدر: Oncogene
Oncogene, 2022, 41 (18), pp.2571-2586. ⟨10.1038/s41388-022-02266-1⟩

مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, MESH: Proto-Oncogene Proteins B-raf, Cancer Research, MESH: Cell Line, Tumor, MESH: Humans, MESH: Melanoma, [SDV]Life Sciences [q-bio], MESH: Phenotype, MESH: Drug Resistance, Neoplasm, [SDV] Life Sciences [q-bio], Discoidin Domain Receptor 2, Phenotype, Drug Resistance, Neoplasm, Cell Line, Tumor, MESH: Cell Proliferation, MESH: Discoidin Domain Receptor 2, Genetics, Humans, MESH: Protein Kinase Inhibitors, Melanoma, Protein Kinase Inhibitors, Molecular Biology, Cell Proliferation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67e902fb034a72453fff297cfa67b184
https://doi.org/10.1038/s41388-022-02266-1

المؤلفون: Marguerite Kandel, Aurélie Bardet, Stéphane Dalle, Clara Allayous, Laurent Mortier, Bernard Guillot, Caroline Dutriaux, Marie-Thérèse Leccia, Sophie Dalac, Henri Montaudie, Philippe Saiag, Delphine Legoupil, Florence Brunet-Possenti, Jean-Philippe Arnault, Julie De Quatrebarbes, Marie Beylot-Barry, Eve Maubec, Thierry Lesimple, François Aubin, Jean-Jacques Grob, Florence Granel-Brocard, Pierre-Emmanuel Stoebner, Alain Dupuy, Brigitte Dreno, Stefan Michiels, Céleste Lebbe, Isabelle Borget

المساهمون: Institut Gustave Roussy [IGR], Oncostat [U1018 (Équipe 2)], Centre Léon Bérard [Lyon], Immunologie humaine, physiopathologie & immunothérapie [HIPI (UMR_S_976 / U976)], Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 [ONCO-THAI], Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], Centre Hospitalier Universitaire de Bordeaux [CHU de Bordeaux], Centre Hospitalier Universitaire [Grenoble] [CHU], Service de Dermatologie (CHU de Dijon), Centre Hospitalier Universitaire de Nice [CHU Nice], Hôpital Ambroise Paré [AP-HP], Centre Hospitalier Régional Universitaire de Brest [CHRU Brest], AP-HP - Hôpital Bichat - Claude Bernard [Paris], CHU Amiens-Picardie, Hôpital Avicenne [AP-HP], Centre Eugène Marquis [CRLCC], Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon], Hôpital de la Timone [CHU - APHM] [TIMONE], Service de Dermatologie et Allergologie [CHRU Nancy], Hôpital Universitaire Carémeau [Nîmes] [CHU Nîmes], Institut de Recherche en Cancérologie de Montpellier [IRCM - U1194 Inserm - UM], CHU Pontchaillou [Rennes], Centre hospitalier universitaire de Nantes [CHU Nantes], Groupe de Recherche et d'Accueil en Droit et Economie de la Santé [GRADES], Institut Gustave Roussy (IGR), Oncostat (U1018 (Équipe 2)), Institut Gustave Roussy (IGR)-Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de Dermatologie [AP-HP Hôpital Saint-Louis], Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Centre Hospitalier Universitaire de Bordeaux (CHU de Bordeaux), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Universitaire de Nice (CHU Nice), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Centre Eugène Marquis (CRLCC), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Hôpital de la Timone [CHU - APHM] (TIMONE), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre hospitalier universitaire de Nantes (CHU Nantes), Groupe de Recherche et d'Accueil en Droit et Economie de la Santé (GRADES), Université Paris-Saclay, This research was funded by the French Institute National of Cancer (DOC 16-009).

المصدر: Current Oncology; Volume 29; Issue 12; Pages: 9255-9270
Current Oncology
Current Oncology, 2022, 29 (12), pp.9255-9270. ⟨10.3390/curroncol29120725⟩

مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, MESH: Melanoma, Cost-Benefit Analysis, Cost-Effectiveness Analysis, [SDV.CAN]Life Sciences [q-bio]/Cancer, JEL: I - Health, Education, and Welfare/I.I1 - Health/I.I1.I18 - Government Policy • Regulation • Public Health, Targeted therapy, Advanced melanoma, Cost-effectiveness analysis, Immunotherapy, Real-life clinical practice, Humans, Prospective Studies, Melanoma, MESH: Proto-Oncogene Proteins B-raf, MESH: Humans, MESH: Cost-Effectiveness Analysis, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [SHS.ECO]Humanities and Social Sciences/Economics and Finance, MESH: Prospective Studies, MESH: France, cost-effectiveness analysis, advanced melanoma, real-life clinical practice, immunotherapy, targeted therapy, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, France, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology, MESH: Cost-Benefit Analysis

وصف الملف: application/octet-stream; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a20b621a3d29eb4dceea5822475fee92
http://hdl.handle.net/20.500.12210/80293

المؤلفون: Klaus Pantel, Zahra Eslami-S, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières

المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE)

المصدر: Clinical Chemistry
Clinical Chemistry, American Association for Clinical Chemistry, 2020, 66 (1), pp.97-104. ⟨10.1373/clinchem.2019.303586⟩

مصطلحات موضوعية: 0301 basic medicine, Proto-Oncogene Proteins B-raf, Proteome, MESH: Proto-Oncogene Proteins B-raf / genetics, Receptor, ErbB-2 / genetics, Receptor, ErbB-2 / metabolism, Transcriptome, ras Proteins / genetics, Receptor, ErbB-2, Clinical Biochemistry, Programmed Cell Death 1 Receptor, MESH: Biomarkers, Tumor / genetics, Biomarkers, Tumor / metabolism, Humans, Liquid Biopsy, Neoplastic Cells, Circulating / metabolism, [SDV.CAN]Life Sciences [q-bio]/Cancer, Computational biology, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Clinical information, medicine, Biomarkers, Tumor, Functional studies, Liquid biopsy, business.industry, Biochemistry (medical), Cancer, medicine.disease, Neoplastic Cells, Circulating, 3. Good health, MESH: Neoplastic Cells, Circulating / pathology, Programmed Cell Death 1 Receptor / genetics, Programmed Cell Death 1 Receptor / metabolism, Proteome / metabolism, 030104 developmental biology, 030220 oncology & carcinogenesis, Tissue biopsies, ras Proteins, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b512907555df9d84e9a4ee41ea857ae
https://hal.umontpellier.fr/hal-02529297

المؤلفون: Arnaud Boyer, Pascale Tomasini, Fabrice Barlesi, Arnaud Jeanson, Laurent Greillier

المساهمون: Service d'oncologie multidisciplinaire innovations thérapeutiques [Hôpital Nord - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], Assistance Publique - Hôpitaux de Marseille (APHM), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU)

المصدر: Expert Review of Anticancer Therapy
Expert Review of Anticancer Therapy, 2019, 19 (1), pp.11-17. ⟨10.1080/14737140.2019.1554440⟩
Expert Review of Anticancer Therapy, Expert Reviews (formerly Future Drugs), 2019, 19 (1), pp.11-17. ⟨10.1080/14737140.2019.1554440⟩

مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, Lung Neoplasms, [SDV]Life Sciences [q-bio], medicine.disease_cause, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, MESH: Molecular Targeted Therapy, MESH: Protein Kinase Inhibitors, Pharmacology (medical), MESH: Animals, Molecular Targeted Therapy, Trametinib, education.field_of_study, 3. Good health, Oncology, 030220 oncology & carcinogenesis, KRAS, Mitogen-activated protein kinase pathway, medicine.drug, Proto-Oncogene Proteins B-raf, MAP Kinase Signaling System, Pyridones, Population, MESH: Pyrimidinones, Pyrimidinones, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, BRAF, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, MESH: Proto-Oncogene Proteins p21(ras), MESH: Pyridones, medicine, Animals, Humans, Lung cancer, education, Protein Kinase Inhibitors, neoplasms, non-small cell lung cancer, MESH: Proto-Oncogene Proteins B-raf, MESH: Humans, business.industry, MESH: MAP Kinase Signaling System, Cancer, Dabrafenib, medicine.disease, digestive system diseases, respiratory tract diseases, MESH: Lung Neoplasms, 030104 developmental biology, Cancer cell, Cancer research, business, MESH: Carcinoma, Non-Small-Cell Lung

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04aa5c306f38c3bb075eda02646b64ad
https://hal.science/hal-02528498

المؤلفون: Balc'h, Eric Le, Grandin, Nathalie, Demattei, Marie-Véronique, Guyétant, Serge, Tallet, Anne, Pagès, Jean-Christophe, Ouaïssi, Mehdi, Lecomte, Thierry, Charbonneau, Michel

المساهمون: Département d'hépato-gastro-entérologie [Hôpital Trousseau : CHRU Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Génétique, immunothérapie, chimie et cancer (GICC), UMR 7292 CNRS [2012-2017] (GICC UMR 7292 CNRS), Université de Tours-Centre National de la Recherche Scientifique (CNRS), Génétique, Reproduction et Développement (GReD), Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), 'LIGUE Grand-Ouest contre le Cancer, comités départementaux d’Eure-et-Loir, Ille-et-Vilaine, Indre, Indre-et-Loire, Morbihan, Vendée, Vienne' (grant #LIGUE-GO-Charbonneau) and the 'Fondation de France' (grant #2011-00020358) to Michel Charbonneau, Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-CHU Trousseau [APHP], Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Génétique, Reproduction et Développement - Clermont Auvergne (GReD), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)-Centre National de la Recherche Scientifique (CNRS)

المصدر: International Journal of Molecular Sciences, Vol 18, Iss 9, p 1871 (2017)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, MDPI, 2017, 18 (9), pp.1-17. ⟨10.3390/ijms18091871⟩
International Journal of Molecular Sciences, 2017, 18 (9), pp.1-17. ⟨10.3390/ijms18091871⟩
International Journal of Molecular Sciences, MDPI, 2017, 18 (9), ⟨10.3390/ijms18091871⟩

مصطلحات موضوعية: Male, Proto-Oncogene Proteins B-raf, KRAS mutations, MESH: Mutation, Class I Phosphatidylinositol 3-Kinases, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer, colorectal cancer, [SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC], Article, MESH: Telomere Homeostasis, Proto-Oncogene Proteins p21(ras), lcsh:Chemistry, MESH: Proto-Oncogene Proteins p21(ras), Biomarkers, Tumor, telomere length, Humans, Pathology, Molecular, lcsh:QH301-705.5, MESH: Pathology, Molecular, MESH: Proto-Oncogene Proteins B-raf, MESH: Humans, Telomere Homeostasis, [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, Telomere, MESH: Class I Phosphatidylinositol 3-Kinases, MESH: Male, lcsh:Biology (General), lcsh:QD1-999, telomere restriction fragment analysis, Mutation, Female, Microsatellite Instability, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Biomarkers, Tumor, MESH: Telomere, Colorectal Neoplasms, MESH: Female, MESH: Colorectal Neoplasms, MESH: Microsatellite Instability

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cb9ae001de5c99a45e313ede8566c4b3
https://www.mdpi.com/1422-0067/18/9/1871

المؤلفون: G. Sassolas, Z. Hafdi Nejjari, A. Ferraro, M. S. Gandhi, C. Kwon Jung, E. Borbone, M. Decaussin Petrucci, B. Rousset, F. Borson Chazot, N. Berger, FUSCO, ALFREDO

المساهمون: registre rhone-alpin du cancer de la thyroide, Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-registre rhone-alpins du cancer de la thyroide, Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), departement de pathologie, Hospices Civils de Lyon ( HCL ), Centre de Recherche en Cancérologie de Lyon ( CRCL ), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -registre rhone-alpins du cancer de la thyroide, Hospices Civils de Lyon ( HCL ) -Hospices Civils de Lyon ( HCL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), G., Sassola, Z., Hafdi Nejjari, A., Ferraro, M. S., Gandhi, C., Kwon Jung, E., Borbone, M., Decaussin Petrucci, B., Rousset, F., Borson Chazot, N., Berger, Fusco, Alfredo

المصدر: Thyroid
Thyroid, Mary Ann Liebert, 2012, 22 (1), pp.17-26. ⟨10.1089/thy.2011.0215⟩
Thyroid, Mary Ann Liebert, 2012, 22 (1), pp.17-26. 〈10.1089/thy.2011.0215〉

مصطلحات موضوعية: Male, Oncology, Pathology, Oncogene Proteins, Fusion, endocrine system diseases, MESH: Carcinoma, Papillary, Endocrinology, Diabetes and Metabolism, Disease, MESH : Oncogene Proteins, Fusion, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, 0302 clinical medicine, Endocrinology, MESH : Child, MESH: Child, MESH : Female, Young adult, Child, Lymph node, education.field_of_study, MESH : Prognosis, MESH : Genes, ras, Thyroid, Age Factors, Protein-Tyrosine Kinases, MESH : Adult, Prognosis, 3. Good health, medicine.anatomical_structure, Thyroid Cancer, Papillary, MESH: Thyroid Neoplasms, MESH: Young Adult, 030220 oncology & carcinogenesis, Female, Mitogen-Activated Protein Kinases, MESH : Mutation, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, MESH: Mutation, Adolescent, MESH : Male, Population, MESH : Young Adult, [SDV.CAN]Life Sciences [q-bio]/Cancer, 030209 endocrinology & metabolism, MESH: Protein-Tyrosine Kinases, MESH: Prognosis, MESH : Carcinoma, Papillary, Thyroid carcinoma, Young Adult, 03 medical and health sciences, Median follow-up, MESH : Adolescent, Internal medicine, MESH : Protein-Tyrosine Kinases, medicine, Humans, Thyroid Neoplasms, education, MESH : Proto-Oncogene Proteins B-raf, MESH: Adolescent, MESH: Age Factors, MESH: Proto-Oncogene Proteins B-raf, MESH: Humans, business.industry, Carcinoma, MESH : Humans, MESH : Mitogen-Activated Protein Kinases, MESH: Adult, MESH: Mitogen-Activated Protein Kinases, Carcinoma, Papillary, MESH : Thyroid Neoplasms, MESH: Male, MESH: Genes, ras, Genes, ras, Mutation, MESH : Age Factors, business, MESH: Female, V600E, MESH: Oncogene Proteins, Fusion

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab5df055f8b0ab0aa992889ca8dc30d
https://doi.org/10.1089/thy.2011.0215

المؤلفون: Olivier Verola, Manuelle Viguier, Frédérique Deshayes, Jessica Lauriol, Dominique Charron, Isabelle Martins, Khaoussou Sylla, Catherine Alcaide-Loridan, Marie-Caroline Dieu-Nosjean, Reem Al-Daccak, Stephanie Ghislin

المساهمون: Institut Jacques Monod (IJM (UMR_7592)), Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Réponses immunes : régulation et développement, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche des Cordeliers (CRC (UMR_S 872)), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Département de Dermatologie, Université Paris, Service d'anatomo-pathologie [Paris], Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CIB-HOG, Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Jacques Monod ( IJM ), Université Paris Diderot - Paris 7 ( UPD7 ) -Centre National de la Recherche Scientifique ( CNRS ), Université Paris Diderot - Paris 7 ( UPD7 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Centre de Recherche des Cordeliers ( CRC (UMR_S 872) ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Diderot - Paris 7 ( UPD7 ) -Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)

المصدر: Melanoma Research
Melanoma Research, Lippincott, Williams & Wilkins, 2009, 19 (4), pp.226-37. ⟨10.1097/CMR.0b013e32832e0bc3⟩
Melanoma Research, Lippincott, Williams & Wilkins, 2009, 19 (4), pp.226-37. 〈10.1097/CMR.0b013e32832e0bc3〉
Melanoma Research, 2009, 19 (4), pp.226-37. ⟨10.1097/CMR.0b013e32832e0bc3⟩

مصطلحات موضوعية: Male, MESH: NF-kappa B p50 Subunit, Cancer Research, Chemokine, Skin Neoplasms, MESH : Aged, MESH: NF-kappa B, MESH : Neoplasm Invasiveness, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, MESH: Aged, 80 and over, 0302 clinical medicine, [ SDV.IMM ] Life Sciences [q-bio]/Immunology, MESH : Female, Extracellular Signal-Regulated MAP Kinases, Melanoma, MESH: Extracellular Signal-Regulated MAP Kinases, Aged, 80 and over, MESH: Aged, Regulation of gene expression, MESH : Trans-Activators, 0303 health sciences, MESH : Prognosis, MESH: Middle Aged, Kinase, NF-kappa B, Nuclear Proteins, MESH: Gene Expression Regulation, Neoplastic, MESH : Adult, Middle Aged, Prognosis, MESH: Chemokines, MESH : Extracellular Signal-Regulated MAP Kinases, Gene Expression Regulation, Neoplastic, Oncology, MESH : NF-kappa B, 030220 oncology & carcinogenesis, Disease Progression, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, MESH: Disease Progression, Chemokines, Matrix Metalloproteinase 1, Adult, Proto-Oncogene Proteins B-raf, MESH: Cell Line, Tumor, P50, MESH : Gene Expression Regulation, Neoplastic, MESH: Melanoma, MESH: Trans-Activators, MESH : Male, MESH : Melanoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, Dermatology, Biology, MESH: Prognosis, 03 medical and health sciences, MESH : HLA-DR Antigens, Cell Line, Tumor, Extracellular, medicine, Humans, MESH : Middle Aged, MESH : Chemokines, Neoplasm Invasiveness, MESH : Aged, 80 and over, Protein kinase A, MESH : Proto-Oncogene Proteins B-raf, Aged, 030304 developmental biology, MESH: Proto-Oncogene Proteins B-raf, MESH: Humans, MESH : Matrix Metalloproteinase 1, MESH : Cell Line, Tumor, MESH: Skin Neoplasms, MESH : Humans, MESH : Skin Neoplasms, MESH: Biological Markers, MESH : Nuclear Proteins, NF-kappa B p50 Subunit, MESH: Adult, MESH : Disease Progression, HLA-DR Antigens, MESH: Neoplasm Invasiveness, MESH: HLA-DR Antigens, medicine.disease, MESH: Male, MESH : Biological Markers, MESH: Matrix Metalloproteinase 1, MESH : NF-kappa B p50 Subunit, Tumor progression, Immunology, Trans-Activators, biology.protein, MESH: Nuclear Proteins, MESH: Female, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b7a96368071a96b16727d82f9f2ae9f
https://doi.org/10.1097/cmr.0b013e32832e0bc3

المؤلفون: Utz Herbig, Neena Mirani, Anitha Suram, Oliver Bischof, Priyanka L. Patel

المساهمون: Rutgers cancer institute of New Jersey [Newark, NJ], Organisation Nucléaire et Oncogenèse / Nuclear Organization and Oncogenesis, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), U.H. was supported by NIH National Cancer Institute Grants R01CA136533 and R01CA184572. O.B. was supported by grants from ANR-BMFT, Foundation ARC pour la recherche sur le Cancer, and Association La Ligue National Contre le Cancer LNCC. O.B. is a CNRS fellow., Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2016, 113 (34), pp.E5024-E5033. ⟨10.1073/pnas.1602379113⟩
Proceedings of the National Academy of Sciences of the United States of America, 2016, 113 (34), pp.E5024-E5033. ⟨10.1073/pnas.1602379113⟩

مصطلحات موضوعية: 0301 basic medicine, Male, MESH: Signal Transduction, Telomerase, Skin Neoplasms, [SDV]Life Sciences [q-bio], senescence escape, MESH: Oncogene Protein p21(ras), Cellular Senescence, telomere, Multidisciplinary, oncogene-induced senescence, MESH: Telomerase, MESH: Gene Expression Regulation, Neoplastic, 3. Good health, Chromatin, Gene Expression Regulation, Neoplastic, PNAS Plus, MESH: Cell Survival, MESH: Epithelial Cells, Female, Signal Transduction, Senescence, Proto-Oncogene Proteins B-raf, MESH: Cell Line, Tumor, DNA damage, Cell Survival, TERT, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Biology, Oncogene Protein p21(ras), telomerase, Cell Line, MESH: Telomere Homeostasis, Proto-Oncogene Proteins c-myc, 03 medical and health sciences, Cell Line, Tumor, MESH: Proto-Oncogene Proteins c-myc, Humans, Telomerase reverse transcriptase, MESH: Proto-Oncogene Proteins B-raf, MESH: Humans, Oncogene, MESH: Skin Neoplasms, Telomere Homeostasis, Epithelial Cells, MESH: Cellular Senescence, Fibroblasts, MESH: Male, Telomere, MESH: Cell Line, 030104 developmental biology, MESH: Fibroblasts, Cancer research, Ectopic expression, MESH: Telomere, MESH: Female, MESH: Breast Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7bff4f65dfdb6b36a5310902c71bd1f
https://hal-pasteur.archives-ouvertes.fr/pasteur-03234938/file/E5024.full.pdf

المؤلفون: Nicolas Ortonne, Issam Abd Alsamad, Nicolas Dumaz, Meriem Chraybi, Maryse Baia, Christiane Copie-Bergman, Jocelyne André

المساهمون: Service d'anatomie et cytologie pathologiques, CHI Créteil, INSERM U955, équipe 9, Département de pathologie [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Immunologie, dermatologie, oncologie, Oncodermatologie, immunologie et cellules souches cutanées (IDO (U976 / UMR_S 976)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10, Guellaen, Georges

المصدر: Human Pathology
Human Pathology, WB Saunders, 2013, 44 (9), pp.1902-11. ⟨10.1016/j.humpath.2013.01.025⟩

مصطلحات موضوعية: Male, Neuroblastoma RAS viral oncogene homolog, MESH: Cyclin D1, DNA Mutational Analysis, cyclin D1, sinonasal melanoma, medicine.disease_cause, MESH: Gene Amplification, GTP Phosphohydrolases, MESH: Aged, 80 and over, 0302 clinical medicine, Epidermal growth factor receptor, MESH: DNA Mutational Analysis, Melanoma, Aged, 80 and over, MESH: Aged, 0303 health sciences, Mutation, MESH: Middle Aged, medicine.diagnostic_test, biology, KIT, DNA, Neoplasm, Middle Aged, CCND1 amplification, 3. Good health, MESH: Proto-Oncogene Proteins c-kit, Proto-Oncogene Proteins c-kit, Real-time polymerase chain reaction, 030220 oncology & carcinogenesis, Female, MESH: Membrane Proteins, Paranasal Sinus Neoplasms, Proto-Oncogene Proteins B-raf, MESH: Mutation, MESH: GTP Phosphohydrolases, MESH: Melanoma, MESH: DNA, Neoplasm, NRAS, Article, Pathology and Forensic Medicine, 03 medical and health sciences, Cyclin D1, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, medicine, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, neoplasms, Aged, Retrospective Studies, 030304 developmental biology, MESH: Paranasal Sinus Neoplasms, MESH: Proto-Oncogene Proteins B-raf, MESH: Humans, Gene Amplification, Membrane Proteins, MESH: Retrospective Studies, Sinonasal Tract, medicine.disease, MESH: Male, BRAF mutation, Primary malignant melanoma of sinonasal tract, Cancer research, biology.protein, MESH: Female, Fluorescence in situ hybridization

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::539155076ca1bd7830441c8b9a7e27af
https://doi.org/10.1016/j.humpath.2013.01.025

المؤلفون: Hélène Frugier, Florence Boissière-Michot, Frédéric Bibeau, Alexandre Ho-Pun-Cheung, Jacqueline Duffour, Evelyne Lopez-Crapez

المساهمون: Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CRLC Val d'Aurelle-Paul Lamarque, CRLCC Val d'Aurelle - Paul Lamarque

المصدر: Virchows Archiv
Virchows Archiv, Springer Verlag, 2016, 469 (2), pp.135-144. ⟨10.1007/s00428-016-1958-1⟩

مصطلحات موضوعية: 0301 basic medicine, MESH: Genes, p16, MESH: Genotype, 0302 clinical medicine, MESH: DNA Methylation, MESH: Germ-Line Mutation, Promoter Regions, Genetic, General Medicine, Methylation, MESH: Colorectal Neoplasms, Hereditary Nonpolyposis, Immunohistochemistry, Lynch syndrome, 3. Good health, MESH: Staining and Labeling, 030220 oncology & carcinogenesis, DNA methylation, DNA mismatch repair, Microsatellite Instability, Proto-Oncogene Proteins B-raf, congenital, hereditary, and neonatal diseases and abnormalities, MESH: Mutation, Genotype, [SDV.CAN]Life Sciences [q-bio]/Cancer, Biology, MLH1, Pathology and Forensic Medicine, 03 medical and health sciences, Germline mutation, MESH: Promoter Regions, Genetic, medicine, Humans, Molecular Biology, Genotyping, neoplasms, MSI, Germ-Line Mutation, Surrogate markers, MESH: Proto-Oncogene Proteins B-raf, MESH: Humans, Staining and Labeling, Genes, p16, Microsatellite instability, nutritional and metabolic diseases, MESH: Immunohistochemistry, Cell Biology, DNA Methylation, medicine.disease, Promoter methylation, Molecular biology, Colorectal Neoplasms, Hereditary Nonpolyposis, digestive system diseases, 030104 developmental biology, Mutation, Cancer research, MESH: Microsatellite Repeats, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, MESH: Microsatellite Instability, Microsatellite Repeats

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e36c93e8aae6fea0743c5d2ae13ec3e
https://pubmed.ncbi.nlm.nih.gov/27220764